ストックスクリーナーアプリを入手
0.7971
0.37%
-0.003
プレマーケット:
.77
-0.0271
-3.40%
Pds Biotechnology Corp (PDSB) 最新ニュース
PDS Biotechnology Corporation (PDSB) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - cnn.com
PDS Biotechnology (NASDAQ: PDSB) Announces Phase 2 VERSATILE-002 Trial Results with 39.3-Month Median Survival - Kalkine Media
PDS Biotech reports 39.3-month survival data for HPV16 therapy By Investing.com - Investing.com Australia
PDS Biotech’s PDS0101 Shows 39.3-Month Median Survival in JAMA Oncology Publication - Minichart
PDS Biotech reports 39.3-month survival data for HPV16 therapy - Investing.com
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology - The Manila Times
A head-and-neck cancer trial reported 39.3 months of median survival - Stock Titan
Patrick Soon-Shiong Secures Board Seat at PDS Biotechnology with 19.9% Stake - TradingView
PDS Biotechnology gets 19.9% Nant Capital stake | PDSB SEC FilingForm SCHEDULE 13D - Stock Titan
PDS Biotechnology updates corporate presentation highlighting PDS0301 clinical data and financing - TradingView
Patrick Soon-Shiong backs PDS Biotechnology (NASDAQ: PDSB) as cancer drugs move toward Phase 3 - Stock Titan
PDS Biotechnology Corporation (PDSB) Options ChainYahoo Finance - Yahoo! Finance Canada
PDS Biotechnology (PDSB) Stock Fair Value Moves Lower After Analyst Cuts And Financing Scrutiny - Yahoo Finance
PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First? - FinancialContent
PDS Biotech Stock Surges Tuesday: What's Driving the Action? - Benzinga
PDS Biotechnology jumps as investors react to PIPE closing and Patrick Soon-Shiong tie-up - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PDS Biotechnology Closes $11.3 Million Initial PIPE Tranche Led by Nant Capital - Minichart
PDS Biotechnology Retires Debt and Secures New Financing - TipRanks
PDS Biotechnology Retires Yorkville $6M Note Early With $4.6M Redemption - TradingView
PDS Biotech Raises $11.3 Million in Initial PIPE Led by Patrick Soon-Shiong - citybiz
PDS Biotechnology Raises $11.3 Million in Initial Closing of PIPE Led by Nant Capital; Dr. Soon-Shiong Joins Board - Quiver Quantitative
Weekly Recap: Up to $22.55M PIPE and HC Wainwright cuts price target to $5 - TradingView
PDS Biotechnology Market Sentiment - Benzinga España
Most Active Stocks on September 8: PDS Biotech, Green Circle, Mobix Labs, Intel and Nokia Lead Volume - ChartMill
Curious about the most active stocks on Tuesday? - ChartMill
PDS Biotech soars as it announces up to $22.55 million financing - thepharmaletter.com
PDS Biotech Jumps as Soon-Shiong-Backed Financing Eases Funding Pressure - Quiver Quantitative
PDS Biotech raises up to USD 22.55m to advance IL-12 immunotherapy toward Phase III in CRC - AllSci
Dow Tumbles 450 Points; US Small Business Sentiment Declines In August - Benzinga
PDS Biotechnology Announces PIPE Financing and Strategic Alignment - TipRanks
PDS Biotech raises up to $22.55M led by Nant Capital - Investing.com Canada
Phase 3 trial plan could unlock $11M more for PDS Biotechnology (NASDAQ: PDSB) - Stock Titan
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks - marketscreener.com
80% survived at least two years in a 22-patient trial of PDS Biotech's cancer treatment - Stock Titan
PDS Biotechnology’s Phase 3 Head and Neck Cancer Trial Termination: What It Means for Investors - TipRanks
PDS Biotech’s Lender Gets 100% of New Non-ATM Equity Cash - ts2.tech
PDSB News | PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) - ChartMill
PDS Biotechnology Amends $6 Million Promissory Note, Tightening Repayment With YA II PN - TradingView
PDS Biotechnology (Nasdaq: PDSB) changes terms on a $6M loan - Stock Titan
Stephan Toutain removed as COO at PDS Biotechnology - TradingView
PDS Biotechnology (PDSB) to shed 36% of staff and part ways with COO - Stock Titan
PDS Biotechnology Corp (NASDAQ: PDSB) Share Price, PDSB Stock News, PDSB Share Price & Updates - Kalkine
Form 8K PDS Biotechnology Corp For: 19 August By Investing.com - Investing.com Nigeria
PDS Biotechnology announces CFO resignation and interim appointments - Investing.com
PDS Biotechnology CFO Lars Boesgaard to Resign; Janetta Trochimiuk and Frank Bedu-Addo Appointed Interim Officers - TradingView
PDS Biotechnology (NASDAQ: PDSB) CEO takes interim finance role as CFO departs - Stock Titan
Weekly Recap: PDS0301 Phase 2 results and Q2 adjusted loss $0.18 - TradingView
PDS Biotechnology shareholders approve charter amendment and director elections - Investing.com
Form 8K PDS Biotechnology Corp For: 14 August By Investing.com - Investing.com Nigeria
PDS Biotechnology (PDSB) wins approval to double authorized stock and elect directors - Stock Titan
PDS Biotechnology (PDSB) cuts R&D spend but warns on going concern, cash at $5.6M - Stock Titan
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):